Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexelvucitabine vs Lamivudine in Treatment-Experienced HIV
NCT00300573Phase 2Terminated
- Sponsor
- Incyte
- Start
- Apr 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of dexelvucitabine in human immunodeficiency virus infection (HIV), sponsored by Incyte. Started Apr 2006; status: terminated.
02
Drugs
dexelvucitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00300573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300573.